Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Fiji Kava Limited ( (AU:CCO) ) is now available.
The Calmer Co. International Limited has appointed Karl Schlobohm as a Non-Executive Director, adding a seasoned governance and capital markets specialist to its board as the company scales globally. Schlobohm brings three decades of experience across ASX, LSE and TSX environments, including senior roles in IPOs, capital raisings and complex corporate transactions, and will receive a base fee of $40,000 per year.
His appointment is expected to strengthen the company’s governance, audit and risk oversight, and ASX compliance as The Calmer Co. pursues U.S. expansion, grows its B2B ingredient supply and advances capital management initiatives. The board and Schlobohm both framed the move as supporting disciplined execution of the growth strategy and enhancing long-term value for shareholders in the expanding market for kava-based products.
The most recent analyst rating on (AU:CCO) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Fiji Kava Limited stock, see the AU:CCO Stock Forecast page.
More about Fiji Kava Limited
The Calmer Co. International Limited is an ASX-listed consumer packaged goods and beverage company focused on kava and other natural products that promote relaxation, sleep support and alcohol alternatives. It sells drinking powders, kava shots, concentrates and capsules under brands including Fiji Kava, Taki Mai and Danodan Hempworks across the U.S., Australia, New Zealand, China and Pacific Islands via e-commerce and retail partners.
Technical Sentiment Signal: Sell
Current Market Cap: A$10.56M
For an in-depth examination of CCO stock, go to TipRanks’ Overview page.